Award
Delivery Order #SPE2D326F6303
Delivery Order for Dexamethasone by Fresenius Kabi under Indefinite Delivery Contract
Buyer
Defense Logistics Agency
Award Amount
$28.85
Ceiling
$28.85
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2D326F6303
NAICS
325411
This award represents a delivery order contract issued to Fresenius Kabi, LLC, a company specializing in pharmaceutical manufacturing and distribution. The contract procures a specific medical product—Dexamethasone 120 mg/30 ml vial—to support healthcare needs. It is a continuation under a broader indefinite delivery contract previously awarded to Fresenius Kabi for supplying critical pharmaceutical products to the U.S. Department of Defense. The contract is significant for ensuring the availability of essential medications critical to military medical preparedness and operational readiness. The scope of work includes timely delivery of the specified pharmaceutical product within a short, defined period at the designated location of Lake Zurich, Illinois. This award follows the existing indefinite delivery contract that was competitively procured to meet the Department's requirements for reliable medical supplies through a responsible acquisition process. The delivery order was recently awarded and covers a brief timeframe in early 2026, underscoring an ongoing effort to maintain steady pharmaceutical supply chains for defense healthcare.
Description
4570915130!DEXAMETHASONE 120 MG/30 ML VL 30ML